Calcium and vitamin D: Skeletal and extraskeletal health
Tóm tắt
Vitamin D is known for its role in calcium homeostasis for optimal skeletal health. It was previously believed that only elderly or hospitalized patients were at risk for vitamin D insufficiency, but many people in the general US population have insufficient levels of 25-hydroxyvitamin D (25[OH]D). According to the Third National Health and Nutrition Examination Survey, 61% of white and 91% of black Americans suffer from vitamin D insufficiency (25[OH]D < 32 ng/mL). Recent studies have demonstrated that a minimum 25(OH)D level of 32 ng/mL is necessary for optimal protection from fracture and intestinal absorption of calcium. Recently, vitamin D has been recognized as important for extraskeletal functions such as immune function, cancer prevention, and hypertension prevention. We review the role of vitamin D in skeletal health and present data on vitamin D in other extraskeletal diseases, with special emphasis on the rheumatology patient.
Tài liệu tham khảo
Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357:266–281. [Comment in: N Engl J Med 2007, 357:1980–1981; author reply 1981–1982. N Engl J Med 2007, 357:1981; author reply 1981–1982. N Engl J Med 2007, 357:1981; author reply 1981–1982. N Engl J Med 2007, 357:1981; author reply 1981–1982.]
Tangpricha V, Spina C, Yao M, et al.: Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr 2005, 135:2350–2354.
Zhou C, Assem M, Tay JC, et al.: Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006, 116:1703–1712. [Comment in: J Clin Invest 2006, 116:2564.]
Walters JR, Balesaria S, Chavele KM, et al.: Calcium channel TRPV6 expression in human duodenum: different relationships to the vitamin D system and aging in men and women. J Bone Miner Res 2006, 21:1770–1777.
Pattanaungkul S, Riggs BL, Yergey AL, et al.: Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 2000, 85:4023–4027.
Walters JR, Balesaria S, Khair U, et al.: The effects of vitamin D metabolites on expression of genes for calcium transporters in human duodenum. J Steroid Biochem Mol Biol 2007, 103:509–512.
Amling M, Priemel M, Holzmann T, et al.: Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140:4982–4987.
Hollis BW, Wagner CL: Normal serum vitamin D levels. N Engl J Med 2005, 352:515–516; author reply 515–516.
Chapuy MC, Preziosi P, Maamer M, et al.: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7:439–443.
Heaney RP, Dowell MS, Hale CA, Bendich A: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003, 22:142–146.
Chapuy MC, Arlot ME, Duboeuf F, et al.: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327:1637–1642.
Chapuy MC, Pamphile R, Paris E, et al.: Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002, 13:257–264.
Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.
Dawson-Hughes B, Harris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670–676. [Comment in: ACP J Club 1998, 128:47. N Engl J Med 1997, 337:701–702.]
Larsen ER, Mosekilde L, Foldspang A: Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004, 19:370–378.
Thomas MK, Lloyd-Jones DM, Thadhani RI, et al.: Hypovitaminosis D in medical inpatients. N Engl J Med 1998, 338:777–783. [Comment in: N Engl J Med 1998, 339:344–345; author reply 345–346. N Engl J Med 1998, 339:345–346. N Engl J Med 1998, 338:828–829.]
van der Wielen RP, Löwik MR, van den Berg H, et al.: Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346:207–210.
Holick MF, Siris ES, Binkley N, et al.: Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215–3224.
Tangpricha V, Pearce EN, Chen TC, Holick MF: Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002 112:659–662.
Jackson RD, LaCroix AZ, Gass M, et al.; Women’s Health Initiative Investigators: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669–683. [Erratum in: N Engl J Med 2006, 354:1102. Comment in: ACP J Club 2006, 145:4–5. Evid Based Nurs 2006, 9:114. N Engl J Med 2006, 354:750–752. N Engl J Med 2006, 354:2285–2287; author reply 2285–2287. N Engl J Med 2006, 354:2285–2287; author reply 2285–2287. N Engl J Med 2006, 354:2285–2287; author reply 2285–2287.]
Porthouse J, Cockayne S, King C, et al.: Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005, 330:1003. [Comment in: ACP J Club 2005, 143:72–74. Age Ageing 2005, 34:542–544. BMJ 2005, 331:108–109; author reply 109. BMJ 2005, 331:108; author reply 109. BMJ 2005, 331:108; author reply 109.]
Grant AM, Avenell A, Campbell MK, et al.: Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005, 365:1621–1628. [Comment in: ACP J Club 2005, 143:72–74. J Fam Pract 2005, 54:658. Lancet 2005, 366:543; author reply 543–544. Lancet 2005, 366:543; author reply 543–544. Lancet 2005 366:544. Lancet 2005, 365:1599–1600.]
Lips P, Graafmans WC, Ooms ME, et al.: Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996, 124:400–406. [Comment in: ACP J Club 1996, 125:16.]
Meyer HE, Smedshaug GB, Kvaavik E, et al.: Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002, 17:709–715.
Boonen S, Lips P, Bouillon R, et al.: Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007, 92:1415–1423.
Bischoff-Ferrari HA, Dawson-Hughes B: Where do we stand on vitamin D? Bone 2007, 41(1 Suppl 1):S13–S19.
Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353–373. [Comment in: Mayo Clin Proc 2006, 81:297–299.]
Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al.: Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 2004, 80:752–758.
Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al.: Effect of vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999–2006.
Cantorna MT, Zhu Y, Froicu M, Wittke A: Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004, 80(6 Suppl):1717S–1720S.
Vaisberg MW, Kaneno R, Franco MF, Mendes NF: Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J Clin Lab Anal 2000, 14:91–96.
Merlino LA, Curtis J, Mikuls TR, et al.; Iowa Women’s Health Study: Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 2004, 50:72–77. [Comment in: Arthritis Rheum 2006, 54:3719–3720.]
Costenbader KH, Feskanich D, Benito-Garcia E, et al.: Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2007, [Epub ahead of print].
Munger KL, Levin LI, Hollis BW, et al.: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832–2838.
Liu PT, Stenger S, Li H, et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770–1773.
Mathieu C, Gysemans C, Giulietti A, Bouillon R: Vitamin D and diabetes. Diabetologia 2005, 48:1247–1257.
Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007, 20:713–719.
Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228–1230.
Judd SE, Nanes MS, Ziegler TR, et al.: Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008, 87:136–141.
Pfeifer M, Begerow B, Minne HW, et al.: Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633–1637.
Hsia J, Heiss G, Ren H, et al.; Women’s Health Initiative Investigators: Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846–854. [Erratum in: Circulation 2007, 115:e466. Comment in: Circulation 2007, 115:827–828. Circulation 2007, 116:e85; author reply e87. Circulation 2007, 116:e86; author reply e87.]
Autier P, Gandini S: Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730–1737.
Lappe JM, Travers-Gustafson D, Davies KM, et al.: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586–1591. [Comment in: Am J Clin Nutr 2007, 86:1804–1805; author reply 1805–1806. Am J Clin Nutr 2007, 86:1549; author reply 1549–1550.]
Huybers S, Naber TH, Bindels RJ, Hoenderop JG: Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6. Am J Physiol Gastrointest Liver Physiol 2007, 292:G92–G97.
Recker RR: Calcium absorption and achlorhydria. N Engl J Med 1985, 313:70–73.
Sakhaee K, Bhuket T, Adams-Huet B, Rao DS: Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther 1999, 6:313–321. [Comment in: Am J Ther 2001, 8:73–74. Am J Ther 2001, 8:74–77.]
Heaney RP, Dowell MS, Bierman J, et al.: Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 2001, 20:239–246.
Recker RR, Bammi A, Barger-Lux MJ, Heaney RP: Calcium absorbability from milk products, an imitation milk, and calcium carbonate. Am J Clin Nutr 1988, 47:93–95.
Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387–5391.
Kamen DL, Cooper GS, Bouali H, et al.: Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006, 5:114–117.
Harvey JA, Zobitz MM, Pak CY: Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988, 3:253–258.